APO Research
Talk to an analyst

APO RESEARCH · REPORT

Atropine

Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.

Selected research

Market Structure

Global Atropine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

9 January 2026197 pages

Choose your research edition.

Industry ResearchAtropine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Atropine Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Atropine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Atropine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Atropine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.

Global Atropine key players include C²PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, CR Double-Crane, Katsura Chemical, etc. Global top five manufacturers hold a share about 35%. China, Europe and North America is the largest market, each with a share about 25%, followed by Japan, with a share about 15 percent. In terms of product, Injection is the largest segment, with a share about 80%. And in terms of application, the largest application is Gastrointestinal, followed by Ophthalmology, etc.

This report provides an overview of the global Atropine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Atropine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Atropine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Atropine market size, projected growth trends, production technologies, key applications, and end-use industries.

Atropine Segment by Company

C²PHARMA

RESONANCE LABORATORIES

ROLABO OUTSOURCING

Minsheng

CR Double-Crane

HENAN PURUI

Albany Molecular Research

Alchem International

SAURAV CHEMICALS

Katsura Chemical

Hangzhou Vega

Wuhan senwayer century

Atropine Segment by Type

Injection

Drop

Gel

Atropine Segment by Application

Gastrointestinal

Ophthalmology

Other

Atropine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atropine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Atropine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atropine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Atropine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Atropine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Atropine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Atropine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Atropine Industry Trends Table 2. Atropine Industry Drivers Table 3. Atropine Industry Opportunities and Challenges Table 4. Atropine Industry Restraints Table 5. Global Atropine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Atropine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Atropine Sales by Manufacturers (Kg) & (2021-2026) Table 8. Global Atropine Sales Market Share by Manufacturers Table 9. Global Atropine Average Sales Price (USD/Kg) of Manufacturers (2021-2026) Table 10. Global Atropine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Atropine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Atropine Manufacturers, Product Type & Application Table 13. Global Atropine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Atropine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Injection Table 17. Major Manufacturers of Drop Table 18. Major Manufacturers of Gel Table 19. Global Atropine Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 20. Global Atropine Sales by Type (2021-2026) & (Kg) Table 21. Global Atropine Sales by Type (2027-2032) & (Kg) Table 22. Global Atropine Sales Market Share by Type (2021-2026) Table 23. Global Atropine Sales Market Share by Type (2027-2032) Table 24. Global Atropine Revenue by Type 2021 VS 2025 VS 2032 (Kg) Table 25. Global Atropine Revenue by Type (2021-2026) & (Kg) Table 26. Global Atropine Revenue by Type (2027-2032) & (Kg) Table 27. Global Atropine Revenue Market Share by Type (2021-2026) Table 28. Global Atropine Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Gastrointestinal Table 30. Major Manufacturers of Ophthalmology Table 31. Major Manufacturers of Other Table 32. Global Atropine Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 33. Global Atropine Sales by Application (2021-2026) & (Kg) Table 34. Global Atropine Sales by Application (2027-2032) & (Kg) Table 35. Global Atropine Sales Market Share by Application (2021-2026) Table 36. Global Atropine Sales Market Share by Application (2027-2032) Table 37. Global Atropine Revenue by Application 2021 VS 2025 VS 2032 (Kg) Table 38. Global Atropine Revenue by Application (2021-2026) & (Kg) Table 39. Global Atropine Revenue by Application (2027-2032) & (Kg) Table 40. Global Atropine Revenue Market Share by Application (2021-2026) Table 41. Global Atropine Revenue Market Share by Application (2027-2032) Table 42. Global Atropine Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 43. Global Atropine Sales by Region (2021-2026) & (Kg) Table 44. Global Atropine Sales Market Share by Region (2021-2026) Table 45. Global Atropine Sales Forecasted by Region (2027-2032) & (Kg) Table 46. Global Atropine Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Atropine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 48. North America Atropine Sales by Country (2021-2026) & (Kg) Table 49. North America Atropine Sales by Country (2027-2032) & (Kg) Table 50. Europe Atropine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 51. Europe Atropine Sales by Country (2021-2026) & (Kg) Table 52. Europe Atropine Sales by Country (2027-2032) & (Kg) Table 53. Asia Pacific Atropine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 54. Asia Pacific Atropine Sales by Country (2021-2026) & (Kg) Table 55. Asia Pacific Atropine Sales by Country (2027-2032) & (Kg) Table 56. South America, Middle East and Africa Atropine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 57. South America, Middle East and Africa Atropine Sales by Country (2021-2026) & (Kg) Table 58. South America, Middle East and Africa Atropine Sales by Country (2027-2032) & (Kg) Table 59. Global Atropine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Atropine Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Atropine Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Atropine Revenue Market Share by Region (2021-2026) Table 63. Global Atropine Revenue Market Share by Region (2027-2032) Table 64. C²PHARMA Company Information Table 65. C²PHARMA Business Overview Table 66. C²PHARMA Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. C²PHARMA Atropine Product Portfolio Table 68. C²PHARMA Recent Development Table 69. RESONANCE LABORATORIES Company Information Table 70. RESONANCE LABORATORIES Business Overview Table 71. RESONANCE LABORATORIES Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. RESONANCE LABORATORIES Atropine Product Portfolio Table 73. RESONANCE LABORATORIES Recent Development Table 74. ROLABO OUTSOURCING Company Information Table 75. ROLABO OUTSOURCING Business Overview Table 76. ROLABO OUTSOURCING Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. ROLABO OUTSOURCING Atropine Product Portfolio Table 78. ROLABO OUTSOURCING Recent Development Table 79. Minsheng Company Information Table 80. Minsheng Business Overview Table 81. Minsheng Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Minsheng Atropine Product Portfolio Table 83. Minsheng Recent Development Table 84. CR Double-Crane Company Information Table 85. CR Double-Crane Business Overview Table 86. CR Double-Crane Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. CR Double-Crane Atropine Product Portfolio Table 88. CR Double-Crane Recent Development Table 89. HENAN PURUI Company Information Table 90. HENAN PURUI Business Overview Table 91. HENAN PURUI Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. HENAN PURUI Atropine Product Portfolio Table 93. HENAN PURUI Recent Development Table 94. Albany Molecular Research Company Information Table 95. Albany Molecular Research Business Overview Table 96. Albany Molecular Research Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Albany Molecular Research Atropine Product Portfolio Table 98. Albany Molecular Research Recent Development Table 99. Alchem International Company Information Table 100. Alchem International Business Overview Table 101. Alchem International Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Alchem International Atropine Product Portfolio Table 103. Alchem International Recent Development Table 104. SAURAV CHEMICALS Company Information Table 105. SAURAV CHEMICALS Business Overview Table 106. SAURAV CHEMICALS Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. SAURAV CHEMICALS Atropine Product Portfolio Table 108. SAURAV CHEMICALS Recent Development Table 109. Katsura Chemical Company Information Table 110. Katsura Chemical Business Overview Table 111. Katsura Chemical Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Katsura Chemical Atropine Product Portfolio Table 113. Katsura Chemical Recent Development Table 114. Hangzhou Vega Company Information Table 115. Hangzhou Vega Business Overview Table 116. Hangzhou Vega Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Hangzhou Vega Atropine Product Portfolio Table 118. Hangzhou Vega Recent Development Table 119. Wuhan senwayer century Company Information Table 120. Wuhan senwayer century Business Overview Table 121. Wuhan senwayer century Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Wuhan senwayer century Atropine Product Portfolio Table 123. Wuhan senwayer century Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Atropine Distributors List Table 127. Atropine Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Atropine Product Image Figure 2. Global Atropine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Atropine Market Size (2021-2032) & (US$ Million) Figure 4. Global Atropine Sales (2021-2032) & (Kg) Figure 5. Global Atropine Average Price (USD/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Atropine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Injection Image Figure 9. Drop Image Figure 10. Gel Image Figure 11. Global Atropine Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 12. Global Atropine Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Atropine Sales Market Share by Type (2021-2032) Figure 14. Global Atropine Revenue by Type (2021 VS 2025 VS 2032) & (Kg) Figure 15. Global Atropine Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Atropine Revenue Market Share by Type (2021-2032) Figure 17. Gastrointestinal Image Figure 18. Ophthalmology Image Figure 19. Other Image Figure 20. Global Atropine Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 21. Global Atropine Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Atropine Sales Market Share by Application (2021-2032) Figure 23. Global Atropine Revenue by Application (2021 VS 2025 VS 2032) & (Kg) Figure 24. Global Atropine Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Atropine Revenue Market Share by Application (2021-2032) Figure 26. North America Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 27. North America Atropine Sales Market Share by Country (2021-2032) Figure 28. U.S. Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 29. Canada Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 30. Mexico Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 31. Europe Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 32. Europe Atropine Sales Market Share by Country (2021-2032) Figure 33. Germany Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 34. France Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 35. U.K. Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 36. Italy Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 37. Netherlands Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 38. Asia Pacific Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 39. Asia Pacific Atropine Sales Market Share by Country (2021-2032) Figure 40. China Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 41. Japan Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 42. South Korea Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 43. Southeast Asia Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 44. India Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 45. Australia Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 46. South America, Middle East and Africa Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 47. South America, Middle East and Africa Atropine Sales Market Share by Country (2021-2032) Figure 48. Brazil Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 49. South Africa Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 50. Saudi Arabia Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 51. Turkey Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 52. Argentina Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 53. UAE Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 54. Egypt Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 55. Chile Atropine Sales and Growth Rate (2021-2032) & (Kg) Figure 56. Global Atropine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Atropine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Atropine Revenue (2021-2032) & (US$ Million) Figure 59. North America Atropine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Atropine Revenue (2021-2032) & (US$ Million) Figure 61. Europe Atropine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Atropine Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Atropine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Atropine Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Atropine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Atropine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Atropine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Drop
  • Gel
Applications
  • Gastrointestinal
  • Ophthalmology
  • Other
Companies covered
  • C²PHARMA
  • RESONANCE LABORATORIES
  • ROLABO OUTSOURCING
  • Minsheng
  • CR Double-Crane
  • HENAN PURUI
  • Albany Molecular Research
  • Alchem International
  • SAURAV CHEMICALS
  • Katsura Chemical
  • Hangzhou Vega
  • Wuhan senwayer century

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Atropine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Atropine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Atropine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Atropine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Atropine Market Dynamics
  1. 2.1 Atropine Industry Trends
  2. 2.2 Atropine Industry Drivers
  3. 2.3 Atropine Industry Opportunities and Challenges
  4. 2.4 Atropine Industry Restraints
3 Atropine Market by Manufacturers
  1. 3.1 Global Atropine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Atropine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Atropine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Atropine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Atropine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Atropine Manufacturers, Product Type & Application
  7. 3.7 Global Atropine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Atropine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Atropine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Atropine Tier 1, Tier 2, and Tier 3
4 Atropine Market by Type
  1. 4.1 Atropine Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Drop
  4. 4.1.3 Gel
  5. 4.2 Global Atropine Sales by Type
  6. 4.2.1 Global Atropine Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Atropine Sales by Type (2021-2032)
  8. 4.2.3 Global Atropine Sales Market Share by Type (2021-2032)
  9. 4.3 Global Atropine Revenue by Type
  10. 4.3.1 Global Atropine Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Atropine Revenue by Type (2021-2032)
  12. 4.3.3 Global Atropine Revenue Market Share by Type (2021-2032)
5 Atropine Market by Application
  1. 5.1 Atropine Application Introduction
  2. 5.1.1 Gastrointestinal
  3. 5.1.2 Ophthalmology
  4. 5.1.3 Other
  5. 5.2 Global Atropine Sales by Application
  6. 5.2.1 Global Atropine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Atropine Sales by Application (2021-2032)
  8. 5.2.3 Global Atropine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Atropine Revenue by Application
  10. 5.3.1 Global Atropine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Atropine Revenue by Application (2021-2032)
  12. 5.3.3 Global Atropine Revenue Market Share by Application (2021-2032)
6 Global Atropine Sales by Region
  1. 6.1 Global Atropine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Atropine Sales by Region (2021-2032)
  3. 6.2.1 Global Atropine Sales by Region (2021-2026)
  4. 6.2.2 Global Atropine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Atropine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Atropine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Atropine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Atropine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Atropine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Atropine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Atropine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Atropine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Atropine Revenue by Region
  1. 7.1 Global Atropine Revenue by Region
  2. 7.1.1 Global Atropine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Atropine Revenue by Region (2021-2026)
  4. 7.1.3 Global Atropine Revenue by Region (2027-2032)
  5. 7.1.4 Global Atropine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Atropine Revenue (2021-2032)
  8. 7.2.2 North America Atropine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Atropine Revenue (2021-2032)
  11. 7.3.2 Europe Atropine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Atropine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Atropine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Atropine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Atropine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 C²PHARMA
  2. 8.1.1 C²PHARMA Company Information
  3. 8.1.2 C²PHARMA Business Overview
  4. 8.1.3 C²PHARMA Atropine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 C²PHARMA Atropine Product Portfolio
  6. 8.1.5 C²PHARMA Recent Developments
  7. 8.2 RESONANCE LABORATORIES
  8. 8.2.1 RESONANCE LABORATORIES Company Information
  9. 8.2.2 RESONANCE LABORATORIES Business Overview
  10. 8.2.3 RESONANCE LABORATORIES Atropine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 RESONANCE LABORATORIES Atropine Product Portfolio
  12. 8.2.5 RESONANCE LABORATORIES Recent Developments
  13. 8.3 ROLABO OUTSOURCING
  14. 8.3.1 ROLABO OUTSOURCING Company Information
  15. 8.3.2 ROLABO OUTSOURCING Business Overview
  16. 8.3.3 ROLABO OUTSOURCING Atropine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ROLABO OUTSOURCING Atropine Product Portfolio
  18. 8.3.5 ROLABO OUTSOURCING Recent Developments
  19. 8.4 Minsheng
  20. 8.4.1 Minsheng Company Information
  21. 8.4.2 Minsheng Business Overview
  22. 8.4.3 Minsheng Atropine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Minsheng Atropine Product Portfolio
  24. 8.4.5 Minsheng Recent Developments
  25. 8.5 CR Double-Crane
  26. 8.5.1 CR Double-Crane Company Information
  27. 8.5.2 CR Double-Crane Business Overview
  28. 8.5.3 CR Double-Crane Atropine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CR Double-Crane Atropine Product Portfolio
  30. 8.5.5 CR Double-Crane Recent Developments
  31. 8.6 HENAN PURUI
  32. 8.6.1 HENAN PURUI Company Information
  33. 8.6.2 HENAN PURUI Business Overview
  34. 8.6.3 HENAN PURUI Atropine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 HENAN PURUI Atropine Product Portfolio
  36. 8.6.5 HENAN PURUI Recent Developments
  37. 8.7 Albany Molecular Research
  38. 8.7.1 Albany Molecular Research Company Information
  39. 8.7.2 Albany Molecular Research Business Overview
  40. 8.7.3 Albany Molecular Research Atropine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Albany Molecular Research Atropine Product Portfolio
  42. 8.7.5 Albany Molecular Research Recent Developments
  43. 8.8 Alchem International
  44. 8.8.1 Alchem International Company Information
  45. 8.8.2 Alchem International Business Overview
  46. 8.8.3 Alchem International Atropine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Alchem International Atropine Product Portfolio
  48. 8.8.5 Alchem International Recent Developments
  49. 8.9 SAURAV CHEMICALS
  50. 8.9.1 SAURAV CHEMICALS Company Information
  51. 8.9.2 SAURAV CHEMICALS Business Overview
  52. 8.9.3 SAURAV CHEMICALS Atropine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 SAURAV CHEMICALS Atropine Product Portfolio
  54. 8.9.5 SAURAV CHEMICALS Recent Developments
  55. 8.10 Katsura Chemical
  56. 8.10.1 Katsura Chemical Company Information
  57. 8.10.2 Katsura Chemical Business Overview
  58. 8.10.3 Katsura Chemical Atropine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Katsura Chemical Atropine Product Portfolio
  60. 8.10.5 Katsura Chemical Recent Developments
  61. 8.11 Hangzhou Vega
  62. 8.11.1 Hangzhou Vega Company Information
  63. 8.11.2 Hangzhou Vega Business Overview
  64. 8.11.3 Hangzhou Vega Atropine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hangzhou Vega Atropine Product Portfolio
  66. 8.11.5 Hangzhou Vega Recent Developments
  67. 8.12 Wuhan senwayer century
  68. 8.12.1 Wuhan senwayer century Company Information
  69. 8.12.2 Wuhan senwayer century Business Overview
  70. 8.12.3 Wuhan senwayer century Atropine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Wuhan senwayer century Atropine Product Portfolio
  72. 8.12.5 Wuhan senwayer century Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Atropine Value Chain Analysis
  2. 9.1.1 Atropine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Atropine Production Mode & Process
  6. 9.2 Atropine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Atropine Distributors
  9. 9.2.3 Atropine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst